Rokea A. el‐Azhary

5.3k total citations
148 papers, 3.5k citations indexed

About

Rokea A. el‐Azhary is a scholar working on Dermatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Rokea A. el‐Azhary has authored 148 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Dermatology, 46 papers in Pathology and Forensic Medicine and 37 papers in Epidemiology. Recurrent topics in Rokea A. el‐Azhary's work include Autoimmune Bullous Skin Diseases (30 papers), Cutaneous lymphoproliferative disorders research (30 papers) and Contact Dermatitis and Allergies (26 papers). Rokea A. el‐Azhary is often cited by papers focused on Autoimmune Bullous Skin Diseases (30 papers), Cutaneous lymphoproliferative disorders research (30 papers) and Contact Dermatitis and Allergies (26 papers). Rokea A. el‐Azhary collaborates with scholars based in United States, United Kingdom and Germany. Rokea A. el‐Azhary's co-authors include Lawrence E. Gibson, James A. Yiannias, Mark R. Pittelkow, David A. Wetter, Marian T. McEvoy, Mark D.P. Davis, Mark D. P. Davis, Gilbert J. Mannering, Mazen S. Daoud and Julia S. Lehman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the New York Academy of Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Rokea A. el‐Azhary

142 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rokea A. el‐Azhary United States	34	1.6k	1.1k	906	522	359	148	3.5k
Amaro García‐Diez Spain	26	1.1k 0.7×	794 0.7×	609 0.7×	465 0.9×	207 0.6×	171	2.7k
Sima Halevy Israel	28	1.9k 1.2×	852 0.8×	1.8k 2.0×	2.2k 4.2×	224 0.6×	137	5.7k
Clara De Simone Italy	34	1.4k 0.9×	745 0.7×	738 0.8×	906 1.7×	82 0.2×	232	4.0k
Lazaros I. Sakkas Greece	38	554 0.4×	676 0.6×	1.4k 1.6×	1.6k 3.1×	82 0.2×	151	4.6k
Michael David Israel	33	1.4k 0.9×	727 0.7×	1.4k 1.6×	776 1.5×	65 0.2×	146	3.5k
Mario García‐Carrasco Mexico	41	242 0.2×	590 0.5×	680 0.8×	2.4k 4.6×	176 0.5×	167	5.1k
Andrea Peserico Italy	33	1.5k 1.0×	664 0.6×	491 0.5×	512 1.0×	52 0.1×	138	3.5k
Philip Bufler Germany	31	555 0.4×	634 0.6×	330 0.4×	271 0.5×	60 0.2×	88	4.3k
Alessandro Borghi Italy	28	951 0.6×	619 0.6×	367 0.4×	610 1.2×	111 0.3×	205	2.6k
Francesco Ciccia Italy	43	526 0.3×	606 0.5×	536 0.6×	3.1k 6.0×	117 0.3×	232	7.1k

Countries citing papers authored by Rokea A. el‐Azhary

Since Specialization

Citations

This map shows the geographic impact of Rokea A. el‐Azhary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rokea A. el‐Azhary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rokea A. el‐Azhary more than expected).

Fields of papers citing papers by Rokea A. el‐Azhary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rokea A. el‐Azhary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rokea A. el‐Azhary. The network helps show where Rokea A. el‐Azhary may publish in the future.

Co-authorship network of co-authors of Rokea A. el‐Azhary

This figure shows the co-authorship network connecting the top 25 collaborators of Rokea A. el‐Azhary. A scholar is included among the top collaborators of Rokea A. el‐Azhary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rokea A. el‐Azhary. Rokea A. el‐Azhary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hickson, LaTonya J., et al.. (2023). High‐risk adverse drug reactions: consideration of limited dialysis therapy for toxic epidermal necrolysis (TEN). International Journal of Dermatology. 63(1). 5–9.

2.

Tkaczyk, Eric R., et al.. (2021). Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review. Transplantation and Cellular Therapy. 27(9). 738–746. 8 indexed citations

3.

Hazim, Antonious, David A. Wetter, Alina G. Bridges, et al.. (2021). Retrospective analysis of 578 inpatient dermatology consultations in hematology and hematopoietic stem cell transplant patients. International Journal of Dermatology. 60(11). 1385–1391.

4.

Lehman, Julia S., Surendra Dasari, Rokea A. el‐Azhary, et al.. (2018). Differential expression of interferon‐induced genes and other tissue‐based biomarkers in acute graft‐versus‐host disease vs. lupus erythematosus in skin. Clinical and Experimental Dermatology. 44(4). e81–e88. 3 indexed citations

5.

Nowsheen, Somaira, et al.. (2018). Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation. Hematology/Oncology and Stem Cell Therapy. 12(1). 19–25. 12 indexed citations

6.

Lehman, Julia S., Tiffany Chen, Christine M. Lohse, & Rokea A. el‐Azhary. (2018). Evaluating the validity of subclassifying warfarin‐associated nonuremic calciphylaxis: a retrospective cohort study. International Journal of Dermatology. 57(5). 572–574. 8 indexed citations

7.

el‐Azhary, Rokea A., et al.. (2017). Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review. British Journal of Dermatology. 177(6). 1510–1518. 19 indexed citations

8.

Alniemi, Dema T., David A. Wetter, Alina G. Bridges, et al.. (2017). Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996–2013. International Journal of Dermatology. 56(4). 405–414. 38 indexed citations

9.

Sokumbi, Olayemi, Rokea A. el‐Azhary, & Loralie J. Langman. (2012). Therapeutic dose monitoring of mycophenolate mofetil in dermatologic diseases. Journal of the American Academy of Dermatology. 68(1). 36–40. 11 indexed citations

10.

Foley, Peter, Michael L. Freeman, Alan Menter, et al.. (2009). Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. International Journal of Dermatology. 48(11). 1236–1245. 67 indexed citations

11.

Souza, Aieska De, Rokea A. el‐Azhary, & Lawrence E. Gibson. (2009). Does pancreas transplant in diabetic patients affect the evolution of necrobiosis lipoidica?. International Journal of Dermatology. 48(9). 964–970. 12 indexed citations

12.

el‐Azhary, Rokea A. & James A. Yiannias. (2004). A new patient education approach in contact allergic dermatitis: the Contact Allergen Replacement Database (CARD)*. International Journal of Dermatology. 43(4). 278–280. 9 indexed citations

13.

Brieva, Joaquin C., et al.. (2001). Successful Treatment of Erosive Lichen Planus With Topical Tacrolimus. Archives of Dermatology. 137(4). 419–419. 72 indexed citations

14.

Yiannias, James A., et al.. (2001). EFFICACY OF CONTACT ALLERGEN REPLACEMENT DATABASE (CARD) IN THE TREATMENT OF ALLERGIC CONTACT DERMATITIS SECONDARY TO TOPICAL SKIN CARE PRODUCT USE. Dermatitis. 12(2). 124–124. 2 indexed citations

15.

Yiannias, James A. & Rokea A. el‐Azhary. (2000). A NEW METHOD TO FACILITATE SUCCESSFUL ANTIGEN AVOIDANCE: DATABASE GENERATED GUIDE OF SKIN CARE PRODUCTS FREE OF THE PATIENTSʼ ALLERGENS. Dermatitis. 11(2). 135–135. 1 indexed citations

16.

Yiannias, James A. & Rokea A. el‐Azhary. (2000). A NEW METHOD TO FACILITATE SUCCESSFUL ANTIGEN AVOIDANCE: DATABASE GENERATED GUIDE OF SKIN CARE PRODUCTS FREE OF THE PATIENTSʼ ALLERGENS. American Journal of Contact Dermatitis. 11(2). 135–135. 1 indexed citations

17.

Gibson, Lawrence E., et al.. (1998). Follicular mucinosis presenting as an acneiform eruption: Report of four cases. Journal of the American Academy of Dermatology. 38(5). 849–851. 31 indexed citations

18.

Daoud, Mazen S., Lawrence E. Gibson, Richard A. DeRemee, et al.. (1994). Cutaneous Wegener's granulomatosis: Clinical, histopathologic, and immunopathologic features of thirty patients. Journal of the American Academy of Dermatology. 31(4). 605–612. 123 indexed citations

19.

el‐Azhary, Rokea A., Lawrence E. Gibson, Paul J. Kurtin, Mark R. Pittelkow, & Sigfrid A. Muller. (1994). Lymphomatoid papulosis: A clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies. Journal of the American Academy of Dermatology. 30(2). 210–218. 70 indexed citations

20.

el‐Azhary, Rokea A. & Aftab Ahmed. (1982). Effect of melphalan on delta-aminolevulinic acid synthetase in the spleen, bone marrow and liver of rats.. Journal of Pharmacology and Experimental Therapeutics. 223(2). 457–461. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact